Visual disability among patients attending glaucoma clinic in a tertiary hospital

Ashour, Doaa Maamoun; Saleh, Mohamed Ibrahim; Awad-Allah, Mo'mena Ahmad A; Abdelgawad, Randa Hesham Ali

doi:10.1007/s10792-021-01724-1

Cited by 1 publication

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previously, GDDs were found to be safe and effective in the management of neovascular and silicone-induced glaucoma [ 15 , 16 ]. Having secondary glaucoma, either neovascular or silicone-filled as the commonest indication might be related to the pattern of referral in Ain Shams Glaucoma Clinic as previously reported by Ashour et al [ 17 ].…”

Section: Discussionmentioning

confidence: 78%

The outcomes of a low-cost, non-valved glaucoma drainage device using mitomycin-C: 1-year results

Awad-Allah

Mousa

Ashour

2023

Graefes Arch Clin Exp Ophthalmol

Self Cite

View full text Add to dashboard Cite

Purpose To evaluate the indications, outcomes, and complications of the usage of Aurolab Aqueous Drainage Implant (AADI) using mitomycin-C. Methods A retrospective case series of patients who underwent AADI placement using mitomycin-C between April 2018 and June 2020 at Ain Shams University Hospitals, Cairo, Egypt. The data was extracted from the records of the patients with a minimum of 1 year of follow-up. Complete success was defined as IOP ≥ 5 mmHg and ≤ 21 mmHg or reduction of IOP by ≥ 20% from baseline without antiglaucoma medications (AGMs). Qualified success was defined as reaching the same IOP range with the aid of AGM. Results A total of 50 eyes of 48 patients were included. Neovascular glaucoma represented the commonest indication (13 patients, 26%). The mean preoperative IOP was 34.0 ± 7.1 mmHg, with a median number of AGM of 3 (mean ± SD = 2.84 ± 1), while the mean IOP after 12 months was 14.3 ± 4 with a median number of AGM of 0. (mean ± SD = 0.52 ± 0.89) (p < 0.001). Complete success was achieved in 33 patients (66%). Qualified success was achieved in 14 patients (28%). Thirteen eyes (26%) had variable postoperative complications; none of them required explantation of the device or affected the visual acuity (except one patient). Conclusion AADI with using mitomycin-C and ripcord during the surgery is an effective and relatively safe method of control of IOP in refractory and advanced cases of glaucoma, with an overall success rate of 94%.

show abstract

Section: Discussionmentioning

confidence: 78%